Tenax Therapeutics, Inc.
TENX· Nasdaq
TENXTenax Therapeutics, Inc.
Filed May 17, 2021 · 10-Q · 47 days after period end · 0001654954-21-005892
| Metric | Q1 2021 | Q1 2020 | Q1 2019 | Q1 2018 |
|---|---|---|---|---|
| Net Income | -$23.75M | -$2.65M | $1.62M | $1.19M |
| EPS Diluted | -$1.64 | -$0.38 | -$0.33 | -$0.84 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Tenax Therapeutics, Inc. · CIK 34956 · Engraved from SEC EDGAR
ended Mar 31, 2021 · filed May 17, 2021 · 47 d after period end
